Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $42.20 Analyst target: $54.38 Upside: 28.86%
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.
See the full interactive analysis & chart →Informational only — not investment advice.